Sanofi’s SNY stock has gained 22.7% in the past three months compared with an increase of 2.9% for the industry. The stock ...

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...

Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and ...

A Chicago jury failed to reach a verdict Sept. 18 over claims that heartburn drug Zantac causes cancer, Reuters exclusively reported.

The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, ...

Time spent above, not below, the target glucose range was associated with mortality in a study of adults with type 2 diabetes ...

The series A financing will enable Nura Bio to advance its lead drug candidate into the next stage of clinical trials, ...

The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, ...

Despite insufficient data, writing panel will give recommendations for preparation, transfer, and follow-up for youth with ...

Editor: The Sanofi TV commercial about the flu is insensitive and thoughtless in its portrayal of the wolf as a dangerous adversary. The disease is personified as a ravenous wolf stalking people in ...

France’s Sanofi has entered into an exclusive licensing agreement with US biotechnology company RadioMedix and French biotechnology company Orano ...

As this year’s respiratory syncytial virus (RSV) season approaches, Beyfortus makers Sanofi and AstraZeneca are making ...